VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1000572
Sex: F
Age:
State:

Vax Date: 01/11/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: Covid 19; Test Result: Positive

Allergies:

Symptoms: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; exposed to Covid positive patient; This is a spontaneous report from a contactable nurse (patient). A 44-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was exposed to Covid positive patient on 15Jan2021. She tested positive for Covid 19 the following Monday 18Jan2021. The patient wanted to know if now that she was positive, she should still proceed with the second dose in February. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded. Occupational exposure to SARS-CoV-2 is most likely related to an intercurrent condition which is not related to the suspected drug. The case will be reassessed if additional information becomes available.

Other Meds:

Current Illness:

ID: 1000573
Sex: F
Age:
State: LA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: daily headache; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient (not pregnant) received BNT162B2 via an unspecified route of administration in the left arm on 13Jan2021 19:45 (07:45 PM) at a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medication included levothyroxine (received within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced daily headache on 14Jan2021. Treatment for the event was not received. The event was non-serious in which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. She was not diagnosed with COVID-19 prior to vaccination. She has not been tested for COVID-19 since the vaccination. The outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1000574
Sex: M
Age:
State:

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: got soreness in the arm; This is a spontaneous report from a contactable consumer (patient): A male patient of unspecified gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 20Jan2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. On an unspecified date after vaccination patient got soreness in the arm. He asked if Tylenol or aspirin could relax the pain. At the time of the reporting event outcome was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1000575
Sex: M
Age:
State: HI

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Covid-19 vaccine was not fully administered to the arm of the patient; in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site; 1 syringe has a leakage; in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site; This is a spontaneous report. A contactable other healthcare professional (hcp) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter stated that they operate a vaccine clinic, and 1 syringe has a leakage, and asked for the reason why the whole dosage didn't go through the patient. He was calling to see if there were guidelines on how to handle that situation. The scenario was where in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site. Reporter was asking if there's guidelines on how to handle with that situation. The Covid-19 vaccine was not fully administered to the arm of the patient. The outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000576
Sex: F
Age:
State: CT

Vax Date: 01/12/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild injection site soreness; more tired than usual which extended into the following day; This is a spontaneous report from a contactable consumer (patient's parent). A 26-years-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 12Jan2021 11:00 to 12Jan2021 11:00 at SINGLE DOSE for covid-19 immunisation. The patient's medical history was not reported. Concomitant medication included etonogestrel (NEXPLANON). On 12Jan2021, the patient had mild injection site soreness and 3-4 hours after receiving the vaccination and noted being more tired than usual which extended into the following day. The events were assessed as non-serious as per the reporter. The patient did not received any treatment for the events. The patient is not pregnant at the time of the report. Outcome of the events was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds: NEXPLANON

Current Illness:

ID: 1000577
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; bad taste; loss of energy; This is a spontaneous report from a Pfizer-sponsored program Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced after the first dose of the vaccine caller experienced headache, bad taste, and loss of energy. The caller also mentioned that he would like to set up an appointment for his second dose. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000578
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; light headedness; shortness of breath; headache; This is a spontaneous report from a non-contactable consumer reporting for a patient. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 vaccination. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unspecified date, the patient experienced chills, light headedness, shortness of breath, and headache. The clinical outcome of chills, light headedness, shortness of breath, and headache was recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000579
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; headache; extreme fatigue; chills; This is a spontaneous report from a non-contactable other HCP communicated to a Pfizer colleague. A female patient of unspecified age, received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on an unspecified date at single dose via an unspecified route of administration for COVID-19 immunization. The patient experienced extreme fatigue and chills after first dose of vaccine. Additional relevant medical history concomitant medications were not reported. On an unspecified date After the second dose, she experienced a headache for 3 days, extreme fatigue, chills and fever. She said she felt like she got every side effect after the second dose. ?Really knocked her off her feet" (as reported). It was reported that she was doing fine now. At the time of the reporting the patient recovered from the events on an unspecified date. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000580
Sex: F
Age:
State: TX

Vax Date: 12/30/2020
Onset Date: 12/01/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 5-decade-old female patient (late 40's) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on 'approx' 30Dec2020 as a single dose, for COVID-19 vaccination. The patient medical history includes ongoing rheumatoid arthritis, ongoing blot clots (previously hospitalized for treatment of blood clots ). Concomitant medication included adalimumab (HUMIRA) and on 'blood thinners for prevention of blood clots'. On Dec2020, the patient experienced pain at injection site (kind of dull pain, very similar to a tetanus shot). 'Just the first day, took some Tylenol so I could sleep and woke up next day feeling fine.' Therapeutic measures were taken as a result of pain at injection site included Tylenol. The clinical outcome of pain at injection site was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: HUMIRA

Current Illness: Clot blood (previously hospitalized for treatment of blood clots and is on blood thinners for prevention of blood clots); Rheumatoid arthritis

ID: 1000581
Sex: F
Age:
State: TX

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at injection site; mild headache; some fatigue; This is a spontaneous report from a non-contactable Consumer via social medica site. This female Consumer (patient) of unknown age reported for herself that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown), via an unspecified route of administration on 19Jan2021 at single dose for an COVID-19 immunisation. The patient medical history included rheumatoid arthritis, on blood thinners for prevention of blood clots (she has been previously hospitalized for treatment of blood clots). Historical vaccine included first dose of BNT162B2 on approximately 30Dec2020 and experienced pain at injection site (kind of dull pain, very similar to a tetanus shot) on first day of vaccination and took some Tylenol so patient could sleep and woke up next day feeling fine. Concomitant medication included adalimumab (HUMIRA). On 19Jan2021, the patient received her second dose of BNT162B2 and experienced the same kind of pain at injection site, mild headache, some fatigue. The patient took Tylenol again and stated that she was still able to do her normal daily household activities (laundry, tidying up, plying w/ dogs, vacuuming, and making sure (son) actually does his school work). Therapeutic measures were taken as a result of events pain at injection site, mild headache, some fatigue included Tylenol. No follow-up attempts are possible. Information regarding Lot/Batch No. cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021058015 Same patient, different dose

Other Meds: HUMIRA

Current Illness:

ID: 1000582
Sex: M
Age:
State: WA

Vax Date: 01/13/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: felt fatigued; This is a spontaneous report from a non-contactable consumer (wife of the patient). A 57-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 13Jan2021 at 09:30 at single dose in left arm for COVID-19 immunisation at the age of 57-year-old. Medical history included allergy and anxiety. Past drug history included allergy to VICODIN. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Dec2020 at single dose in left arm for COVID-19 immunisation at the age of 57-year-old. Concomitant medications included unspecified drugs for allergy and anxiety. The patient said to the consumer just at the time of report that he felt fatigued the morning after his second shot on 14Jan2021 at 06:00. The patient was not treated for the event. The patient recovered from the event. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1000583
Sex: F
Age:
State: NC

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: COVID 19; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptoms: bilateral sharp leg muscle pain; difficulty to move around; severe fatigue; This is a spontaneous report from a non-contactable Other Healthcare Professional reporting for herself A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 04Jan2021 at single dose via an unspecified route of administration for COVID-19 immunization. The patient didn't have medical history. Concomitant medications included ibuprofen 1 dose of over the counter Ibuprofen a day prior to vaccination. On an unspecified date in Jan2021 after the 1st dose patient experienced bilateral sharp leg muscle pain causing difficulty to move around and severe fatigue. The events lasted daily for more than 1 week. Treatment received included Tylenol. It was informed that 2nd dose should be administered the week of 25Jan2021. The patient recovered from the events on an unspecified date. Information on the lot/batch number has been requested.

Other Meds: IBUPROFEN

Current Illness:

ID: 1000584
Sex: F
Age:
State: AZ

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: mental fogginess; fatigue; muscle tightness/aches; muscle tightness/aches; This is a spontaneous report from a contactable pharmacist (patient). A 31-year-old female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on 20Jan2021 01:30 PM (vaccine location: Left arm) at single dose for COVID-19 immunisation. Previous vaccine included first dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on 30Dec2020 04:00 PM (vaccine location: Left arm) at single dose for COVID-19 immunisation. The patient's medical history included controlled asthma and obesity. The concomitant medications were reported as fluticasone nasal, prenatal, colecalciferol (Vit D3) 5000 IU. There was no other vaccines within 4 weeks prior to the COVID vaccine. Patient experienced fatigue, mental fogginess, muscle tightness/aches on 21Jan2021 11:00 AM. The outcome of events was recovering after self-administered ibuprofen 800 mg x1. Information on the batch/Lot number has been requested.

Other Meds: FLUTICASONE; VIT D3

Current Illness:

ID: 1000585
Sex: F
Age:
State: CA

Vax Date: 01/11/2021
Onset Date: 01/12/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210118; Test Name: PCR; Test Result: Negative

Allergies:

Symptoms: Sudden onset of Hypertension with out history; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient received first single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (Vaccine location: Left arm) on 11Jan2021 07:15 for Covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered: Hospital. Medical history included allergy to beer. The patient was not pregnant. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications patient received within 2 weeks of vaccination. The patient experienced sudden onset of hypertension (without history) on 12Jan2021 06:00. Event required doctor or other healthcare professional office/clinic visit. The event was considered as non-serious by the reporter. Treatment received for the adverse event included oral lisinopril 10 mg. Nasal swab (PCR) on 18Jan2021 was negative. The patient had not recovered from sudden onset of hypertension at the time of reporting. Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 1000586
Sex: F
Age:
State: TN

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: chills; sweating; dizziness; headache; head rash; general tiredness/bad lethargy/ more tired; muscle aches; Nausea/ sick to her stomach; Vomiting/ throwing up; sore throat; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Jan2021, the patient was having side effects like vomiting, sore throat, sweating, dizziness, head rash, general tiredness, muscle aches, and nausea, the patient was wondering if she can go to the hospital. She got her vaccine on 15Jan2021 and had a tiny reaction right away that went away in 20 minutes; sweating, dizziness and a headache. After that she felt a little more tired than usual, but it has progressed more and more everyday; she has been more and more tired. On 22Jan2021 she had some chills, and was feeling a little worse and worse, then yesterday she had a headache and a little bit of a sore throat. Stated that she went home from work yesterday and went right to bed at 2pm because she was so tired. Today, she woke up again really tired but went in to work, and then this after she got so sick to her stomach and started throwing up. Now, she can't keep anything down. Stated that she just kept feeling worse and worse. "Is this Covid? Or is it from the vaccine?" It was starting to scare her. It felt like she almost has food poisoning at this point, but with really bad lethargy, a headache, and really bad chills. Outcome of the events sweating and dizziness was recovered on 15Jan2021, while unknown for the other events. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000587
Sex: M
Age:
State: MD

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Mild tingle in tip of tongue 30 minutes after injection; This is a spontaneous report from a contactable 43-year-old male consumer reported for himself who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (lot number EL9261/expiration date: unknown), via unknown route of administration, on 21Jan2021 07:45 AM (at the age of 43 years old) as a single dose on left arm for COVID-19 immunisation at a hospital. Relevant medical history included and concomitant medications were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021 at 08:15 AM, the patient stated that he experienced mild tingle in tip of tongue 30 minutes after injection. The patient received no treatment for the event. The outcome of the event "mild tingle in tip of tongue 30 minutes after injection" was recovered. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1000588
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches; Fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported for a female patient (Daughter) A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on an unspecified date at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history and concomitant medications were not reported. Reporter mentioned that her daughter got the vaccine and on an unspecified date had body aches and fever. It was also informed that patient had symptoms like covid, and reporter also asked if her daughter was now positive with Covid after the first dose (as such). At the time of the reporting event outcome was unknown. Information on the Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1000589
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle pain; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. The patient medical history and concomitant medications were not reported. After the first dose, on an unspecified date, the patient experienced muscle pain. The patient will go to the doctor because of her experience. The patient also had questions about how long the vaccine will protect her from the virus. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000590
Sex: F
Age:
State: CT

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain at injection site; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient not pregnant received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the Right arm on 20Jan2021 at 02:45 PM as a single dose for COVID-19 immunisation, lot number: unknown. Medical history was not provided. Patient had no allergies to medications, food, or other products. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications in two weeks prior to the vaccination included cetirizine hydrochloride (ZYRTEC ALLERGY), curcuma zanthorrhiza (CURCUMEN TUERMERIC), ubidecarenone (CO-ENZYME Q10) and Beet roo (as reported). Patient did not receive other vaccine in four weeks prior to the COVID vaccine. On 21Jan2021 at 06:15 AM patient experienced pain at injection site when she woke up this morning which had lasted through the day. No treatment was received for the event. Since the vaccination patient had not been tested for COVID-19. Patient had not recovered from the event, at the time of the report. Information on the lot/batch number has been requested.

Other Meds: ZYRTEC ALLERGY; CURCUMEN TUERMERIC; CO-ENZYME Q10

Current Illness:

ID: 1000591
Sex: F
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: A little bit dizzy; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer (patient) reported that a female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on 20Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first shot today 20Jan2021. She was a little bit dizzy but okay now. Wanting to know if I'm okay to have a congratulatory champagne. Outcome of the event was recovered on 20Jan2021. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000592
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/13/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210113; Test Name: COVID; Test Result: Positive

Allergies:

Symptoms: patient tested positive for covid virus; patient tested positive for covid virus; This is a spontaneous report from a contactable consumer (patient), received via a Pfizer-sponsored program. A 54-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 07Jan2021 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that on 13Jan2021, the patient tested positive for covid virus. The patient would like to know about getting the second dose of vaccine. Outcome of the event was unknown. Information about Lot/Batch number has been requested.

Other Meds:

Current Illness:

ID: 1000593
Sex: F
Age:
State: AZ

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Fahrenheit

Allergies:

Symptoms: delirious dreams; extreme chills; so cold that it felt like burning ice cubes on skin, could not get warm even with multiple blankets; severe body aches; severe headache; fever of 101; nausea; thirsty; Symptoms began to abate today (almost 48 hours later) but still fet some foggy thinking; This is a spontaneous report from a contactable other health care professional (patient) and a contactable consumer. A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELIZ83), via an unspecified route of administration at arm left on 19Jan2021 at single dose for COVID-19 immunization. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received fist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) via an unspecified route of administration at arm left on 29Dec2020 at 9:30 at single dose for COVID-19 immunization. On Jan2021, the patient reported that 15 hours after second dose, he experienced extreme chills, so cold that it felt like burning ice cubes on his skin, he couldn't get warm even with multiple blankets, severe body aches, fever of 101 F, severe headache, delirious dreams, nausea, thirsty and feel some foggy thinking. The patient outcome of the event was recovering.

Other Meds:

Current Illness:

ID: 1000594
Sex: M
Age:
State: IL

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fever; Chills; Headache; Muscle aches; Injection site burning and soreness for 36 hours; This is a spontaneous report from a contactable healthcare professional (the patient). A 26-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number EL9262), intramuscular in the left arm on 20Jan2021 10:30 (at the age of 26-years-old) as a single dose for COVID-19 immunization. Medical history included asthma, and the patient was diagnosed with COVID-19 prior to vaccination. The patient did not have any allergies to medications, food, or other products. The patient did not have any concomitant medications. The patient had not received any other vaccine within 4 weeks prior to the vaccine. On 21Jan2021, the patient experienced fever, chills, headache, muscle aches, injection site burning and soreness for 36 hours (as reported). The patient did not receive treatment for these events. The clinical outcome of fever, chills, headache, muscle aches, injection site burning and soreness was recovering (as reported). It was also reported that since the vaccination, the patient had not been tested for COVID-19. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1000595
Sex: F
Age:
State: AL

Vax Date: 12/23/2020
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches, pain; pain and swelling at injection site; pain and swelling at injection site; HSV2 outbreaks; This is a spontaneous report from a nurse (patient herself). A 48-year-old female patient (not pregnant) received bnt162b2 (BNT162B2 also reported as COVID 19 vaccine, brand Pfizer), second dose in left arm on 13Jan2021 (lot EL1283) and first dose in right arm on 23Dec2020 09:15 (lot EK5730), via an unspecified route of administration at single dose, for Covid-19 immunisation. Medical history was none. No any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included colecalciferol (VITAMIN D). On 15Jan2021 20:00, she had body aches, pain and swelling at injection site and HSV2 outbreaks with both doses. First was more severe than the second and took longer to heal. No treatment was given. The outcome of events was recovered.

Other Meds: VITAMIN D

Current Illness:

ID: 1000596
Sex: M
Age:
State: WA

Vax Date: 01/17/2021
Onset Date: 01/18/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash blisters with clear fluid forming on neck back and chest.; Rash blisters with clear fluid forming on neck back and chest.; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; Burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor prescribed shingles medication and tramadol; prescribed shingles medication; This is a spontaneous report from a contactable other healthcare professional (patient). A 56-year-old male patient receive second single dose of BNT162B2 (Pfizer, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration (vaccine location: Left arm) on 17Jan2021 13:15 for Covid-19 immunization. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. There was no relevant medical history. Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took first single dose of BNT162B2 (Pfizer) on 27Dec2020 14:00, vaccine location: Left leg, for Covid-19 immunization. On 18Jan2021 06:00, the patient experienced rash blisters with clear fluid forming on neck, back, and chest. There was also burning pain coming in waves pustules that were clear have ruptured and reformed. Went to doctor wherein patient was prescribed shingles medication and tramadol. The events were considered as non-serious by the reporter. The events resulted in Doctor or other healthcare professional office/clinic visit. The patient was recovering from pustule while the outcome of the other events was not recovered. Information about lot number and expiry date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 1000597
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain at injection site; fever; This is a spontaneous report from a non-contactable consumer. An adult male patient received BNT162B2 (lot not available/provided) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced pain at injection site and fever on unspecified dates. It was noted that it was forgotten if it was pain at injection site or fever the day after. The events were non-serious in which did not result in death, not life threatening, did not caused/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000598
Sex: F
Age:
State: NJ

Vax Date: 01/14/2021
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: his wife had chills; she did feel pain; had a sore arm; This is a spontaneous report from a contactable Consumer (patient's husband). A 93-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient had chills and feel pain and had a sore arm. Outcome of the events was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1000599
Sex: F
Age:
State: CA

Vax Date: 01/19/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Joint pain; Fatigue; Headache; Pain and swelling at injection site; Pain and swelling at injection site; makes me feel sick/ malaise; Muscle pain; Nausea; Fever; This is a spontaneous report from a non-contactable nurse reporting for herself. A female patient of unspecified age received the second dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration, on 19Jan2021 at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (BNT162B2, lot number and expiry date were not reported), on an unspecified date for COVID-19 immunization. The patient experienced the following on an unspecified date in Jan2021 after her 2nd dose of COVID 19 vaccine: "This Covid 19 vaccine makes me feel sick. Experiencing the following after my second dose: Pain and swelling at injection site, Fatigue/ malaise, Headache, Muscle pain/ Joint pain, Fever, and Nausea." Outcome of the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000600
Sex: M
Age:
State: MD

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site pain; Arm pretty sore; This is a spontaneous report from a contactable physician who reported for himself. A 58-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; solution for injection; Lot #: EJ1685) via an unspecified route of administration on 23Dec2020 at 09:00 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included a history of anaphylaxis to latex which predated treatment with the Pfizer COVID-19 vaccine, heart rate control, hypertension and high cholesterol; all from unspecified dates and unspecified if ongoing. It was also reported that the patient's medical history was "none" and that the patient had no illness at the time of vaccination. Family medical history was reported as "none". Concomitant medications included ongoing metoprolol taken for heart rate control taken from an unspecified date ("taking for two years"), ongoing telmisartan taken for hypertension orally from an unspecified date ("taking for two years") at 1x/day (take once daily by mouth) and ongoing rosuvastatin calcium (CRESTOR; strength: 40mg) taken for high cholesterol from an unspecified date ("taking for 10 years") at 40mg, 1x/day. The patient did not receive any additional vaccines on the same date of the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Dec2020 the patient experienced "injection site pain" and "arm pretty sore". It was reported that "a physician called regarding the Pfizer COVID-19 vaccine. The patient reported that he received the second dose of the vaccine on Thursday and was advised by his medical director to call Pfizer to report his symptoms. He reported that he received the first dose of the Pfizer COVID-19 vaccine three weeks prior to the second dose. The patient first stated that was about 14Dec2020, but then clarified that per his vaccine card, he received the first dose of the vaccine on 23Dec2020 at 0900AM in the left arm. The patient stated that he noticed injection site pain that lasted about two days and his arm was pretty sore. Both events completely resolved before the second dose." It was reported that the events did not require a visit to the physician or to the ER. It was reported that there were no relevant tests. The clinical outcomes of the events "injection site pain" and "arm pretty sore" were both recovered/resolved on 15Jan2021. The reporter considered that there was reasonable possibility (method of assessment: Global introspection) that the events "injection site pain" and "arm pretty sore" were related to BNT162B2.

Other Meds: METOPROLOL; TELMISARTAN; CRESTOR

Current Illness:

ID: 1000601
Sex: F
Age:
State: FL

Vax Date: 01/15/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: temperature; Result Unstructured Data: Test Result:97

Allergies:

Symptoms: Confused; Disorientated; Sleeping a lot/Groggy; Headache; Felt very weak, felt very tired; felt very panicky; Dizziness; Felt like she had the flu; Chills; pain in her neck; she was cold; This is a spontaneous report from a contactable consumer (patient). This 89-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number PFREL1283, Expiration Date 30Apr2021), via intramuscular, on 15Jan2021 (at 12:00) at a single dose on the left arm for COVID-19 immunisation. Relevant medical history included ongoing lymphoedema (she gets water in her legs), ongoing severe arthritis of both knee caps (she had a cortisone shot and lidocaine in her knees), and dust allergy. Historical vaccine included flu vaccine received in Jan2020 and in Oct2020 (with terrible reaction: pain in arm, numb in arm and muscle pain arm for 6 weeks). Past drug history included allergy to lidocaine (her face swelled up), and hydrocortisone (CORTISONE). She was in a wheelchair. Surgical history included 2 hip replacements. Relevant concomitant medications included drug for lymphoedema. The patient stated she started having side effects almost immediately after receiving the COVID-19 vaccine. She felt very panicky, felt very weak, felt very tired. She had like a headache. Some of the symptoms started the day she got the shot and then more symptoms arose the day after. She was very tired and was sleeping a lot the next day. She felt very like groggy. In fact, she was so groggy, she pressed the wrong button in her chair. She clarified she has lymphedema and she has to be in a lift chair to keep her legs elevated. When she needs to get up, she presses a certain button to raise and lift the chair into a sitting position. However, that day, her doorbell rang (her meals are delivered to her) and she was so groggy and confused, that she pressed the button that put her straight out into a lying position instead of a sitting position. She ended up sliding off the chair and onto the floor. She had to call for assistance (there is an emergency button she can press). She had to be lifted off the floor. She explained to them she didn't end up on the floor from walking, she slid off the chair. She was so disoriented she pressed the wrong button. She felt like she had the flu, she was cold, she had the chills. She was laying down, covered up with 2 blankets. She couldn't move. It was terrible. At the time, she slid off the chair, she had to go the bathroom. She is on a water pill which makes things worse, but she has a bedside commode close to her lift chair. When she was trying to get off the chair go to the bathroom (which is only 4 or 5 steps away from the commode), she was so disoriented, she pressed the wrong button. She has had this chair for 5 years. She slid off the chair and ended up hitting the floor with her rear end. She remained on the nice cold floor (its a ceramic tile floor) until they came to pick her up. She mentioned she has had 2 hip replacements and once she is on the floor, she can't get up. Once assistance from where she lives came to pick her up, she was asked if she need to go the hospital or call ambulance. She explained to them she didn't fall. She slid off the chair. She is a very active person. Although she is almost 90, year is not senile. She slid off the chair, she didn't fall. The patient stated that she got the flu shot this past October and had a terrible reaction to that, too. Therefore, she doesn't know if it's just her system. She has had a flu shot every single year for the past 10-15 years and she has never had a reaction at all. She received the regular flu shot at her doctor's office in Oct2020 had a terrible reaction, she had severe pain in her arm where they gave her the shot, the pain wasn't at the injection site, the shot was high up the arm, her arm was numb and she couldn't raise it; she had muscle problems with the arm, she had trouble with her arm for 6 weeks. She has been taking naproxen sodium (ALEVE) for the headache. She has just been treating it symptomatically. No fever and she has just felt cold. The patient stated she really is not sick. She went to pick up dog medicine from the vet and when she leaves her facility, her temperature is always checked when she comes back. She was told her temperature was 97 something. So, she wasn't running any temperature prior to the vaccine. The patient was planned for the second dose on 05Feb2021. The patient stated her symptoms are not so severe it affects her breathing or something serious. It's just a pain in her neck to walk around with a headache. The outcome of the events was unknown.

Other Meds:

Current Illness: Arthritis (severe arthritis of both knee caps, she had a cortisone shot and lidocaine in her knees); Lymphedema (Lymphedema, she gets water in her legs)

ID: 1000602
Sex: M
Age:
State: MI

Vax Date: 01/20/2021
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Name: lab work; Result Unstructured Data: Test Result:Unknown results; Comments: I had lab work but that's connected with some kind of surgery or my pacemaker or something like that. But nothing outside of that.; Test Name: weigh; Result Unstructured Data: Test Result:185; Comments: I weigh about 185; Test Name: weigh; Result Unstructured Data: Test Result:'ticking' a little bit; Test Name: weigh; Result Unstructured Data: Test Result:increasing

Allergies:

Symptoms: My arm is little sore; This is a spontaneous report from a contactable consumer reporting for himself. A 95-years-old male patient received BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on 20Jan2021 at single dose for COVID-19 immunization. The patient also received apixaban (ELIQUIS), 2 dose forms (DF) every day, via an unspecified route of administration from an unspecified date at an unknown dose as blood thinner. Medical history included a bone spur in the left foot that causes the patient to limp a bit, although he is still able to move around a little bit ("he is surprised that he is still plodding along"), cardiac pacemaker insertion, body weight sometimes increasing, a trouble with his vision, so he has a restricted driver's license: he can only drive during the day time. The patient is also a hearing aid user from an unknown date and has central nervous system stimulation from an unknown date ("I have Neuraxis"). His wife says that "he has them every day". Past drug history included warfarin sodium (COUMADIN) used for years as blood thinner. The patient's concomitant medications were not reported, although the patient stated he takes a lot of medications. The patient reported that the vaccine "worked beautifully", but only after the shot he could read on the information sheet that the he should have told the provider about all his medical conditions, if he has a bleeding disorder or is on a blood thinner. Now he's reluctant to take his pills because of this warning. He feels fine, he doesn't have any problems with the shot. He only stated that his arm was little sore but that's to be expected. The patient would like to know if he can continue to take his blood thinner. On an unknown date the patient underwent lab tests connected with some kind of surgery or his pacemaker whose results were unknown. The action taken with apixaban in response to the event was unknown. The event outcome was unknown at the time of the report. Information on the lot/batch number has been requested.

Other Meds:

Current Illness: Weight increased

ID: 1000603
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: swollen lymph nodes along the collar bone; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female of unspecified age received bnt162b2 (reported as COVID-19 vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received vaccine Friday (unspecified date) and had developed swollen lymph nodes along the collar bone on an unspecified date. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000604
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; incredible fatigue; headache; This is a spontaneous report from a contactable health care professional nurse, the patient. A female patient (nurse) of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: unknown), via an unspecified route of administration on unspecified date as a single dose, for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced incredible fatigue, and body aches followed with a headache for about 24 hours. The clinical outcome of the events fatigue, body aches and headache was unknown. No follow-up attempts are possible; information about lot number cannot be obtained

Other Meds:

Current Illness:

ID: 1000605
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: muscle aches; Joint pain; Tingling; Fatigue; Little more stiff; sore than usual; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 and she had "incredible fatigue, and body aches followed with a headache" for about 24 hours. Five hours after second dose, the patient experienced muscle aches, joint pain, tingling, and fatigue lasted about 30 hours- it has resolved just a little more stiff /sore than usual. The outcome of the events little more stiff, and sore was unknown while recovered for the other events. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1000606
Sex: U
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patient reported a sore arm for 3 days; This is a spontaneous report from a contactable nurse. This nurse reported that a patient of unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number/Exp. date unknown), via an unspecified route of administration on unknown date at single dose for an COVID-19 immunisation. The patient medical history and concomitant medications were not provided. The patient reported a sore arm for 3 days on unknown date after vaccination. The outcome of event sore arm was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1000607
Sex: F
Age:
State: OH

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Heavy headed (not headache); malaise; chills; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9261, expiry date unknown), intramuscular at the left arm on 20Jan2021, 11:30 at single dose for COVID-19 immunization. The patient's medical history included hypertension, hyperkeratosis lenticularis perstans, osteoarthritis, allergies to medication, food, or other products, and COVID-19 diagnosed prior to vaccination. The patient's concomitant medications were not reported. The patient was not tested for COVID-19 since vaccination. Patient was not pregnant at the time of vaccination. On 21Jan2021, 05:00, the patient experienced heavy headed (not headache), malaise and chills. Patient felt like her 2nd day of COVID, afebrile. The patient received ibuprofen (ADVIL) 600 mg for the events. The outcome of the events was recovered on an unspecified date. The events were non-serious.

Other Meds:

Current Illness:

ID: 1000608
Sex: F
Age:
State: VA

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210119; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Comments: Nasal Swab

Allergies:

Symptoms: Dizziness; nausea; headache; constant eye and nose drain; constant eye and nose drain; burning eye and nose; burning eye and nose; weakness; tiredness; sore lips and throat; sore lips and throat; sore on tongue; chest tightness; This is a spontaneous report from a contactable consumer reporting for herself. A 62-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose at left arm on 14Jan2021 11:30 for Covid-19 immunisation, administered at hospital. Medical history included hypertension, high cholesterol, diabetes mellitus, allergies penicillin. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication within 2 weeks of vaccination included atenolol (manufacturer unknown), losartan (manufacturer unknown), atorvastatin (manufacturer unknown), hydrochlorothiazid (manufacturer unknown). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Jan2021 07:00 the patient experienced dizziness, nausea, headache, constant eye and nose drain, burning eye and nose, weakness, tiredness, sore lips and throat, sore on tongue, chest tightness. The patient underwent lab tests and procedures which included Sars-cov-2 nasal swab test: negative on 19Jan2021. The outcome of all events was not recovered as all ongoing now for 1 week. The events were considered non serious. Information on the lot/batch number has been requested.

Other Meds: ATENOLOL; LOSARTAN; ATORVASTATIN; HYDROCHLOROTHIAZID

Current Illness:

ID: 1000609
Sex: F
Age:
State: OH

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: body aches; chills; sweats; migraine; light sensitivity; This is a spontaneous report from a contactable healthcare professional (patient). A 28-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261), intramuscular on left arm on 20Jan2021 at 13:00 at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not allergic to medications, foods, or other products. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and multivitamin. The patient was not pregnant at the time of vaccination. The vaccine was administered at the patient's workplace clinic. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced body aches, chills, sweats, migraine, and light sensitivity, all on 21Jan2021 at 09:00. She did not receive any treatment for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and has not been tested for COVID-19 since the vaccination. The outcome of the events was recovered on Jan2021. No follow-up attempts are possible. No further information is expected.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1000610
Sex: F
Age:
State: VA

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection Site Pain/Muscle Pain- ongoing soreness; Injection Site Pain/Muscle Pain- ongoing soreness; General Fatigue; Headache; Chills; Chest Pain; Fever; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself. A 23-year-old female patient received second dose of bnt162b2 (manufacturer: Pfizer, lot number and expiration date: unknown), via an unspecified route of administration on her left arm on 21Jan2021 09:45 at single dose for covid-19 immunization. The patient's medical history included anaemia from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously took the first dose of bnt162b2 on 02Jan2021 for covid-19 immunization. On 22Jan2021 at 00:30, the patient experienced injection site pain/muscle pain-ongoing soreness, general fatigue, headache, chills, chest pain, and fever. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000611
Sex: M
Age:
State: WI

Vax Date: 01/21/2021
Onset Date: 01/22/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Fever; Result Unstructured Data: Test Result:100.3 Fahrenheit; Test Date: 20201127; Test Name: tested covid; Test Result: Positive

Allergies:

Symptoms: Fever just measured at 100.3F; feeling pretty miserable; Joint pain; aches; chills; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL3249), via an unspecified route of administration on 21Jan2021 10:15 at SINGLE DOSE for COVID-19 immunisation. The vaccine location was at the right arm and patient received the first dose of the vaccine. The patient was administered COVID-19 vaccine at the hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included diagnosis of COVID-19 prior to vaccination, chronic sinusitis, anxiety, depression, and attention deficit hyperactivity disorder (ADD). The patient had no allergies to medications, food, or other products. Concomitant medications included sertraline hydrochloride (ZOLOFT), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), clarithromycin, and clonazepam. The patient stated, "I have tested covid + the day after Thanksgiving and this feels just like it minus the respiratory symptoms. Pretty much all the signs of an immune response. Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills." The events started on 22Jan2021 at 05:00 AM. The reporter considered the events as non-serious. There was no treatment received for the events. It was also reported that since the vaccination, the patient has not been tested for COVID-19. The patient underwent lab test and procedure on 27Nov2020 which included COVID test which showed positive. The patient had not yet recovered from the events "Fever just measured at 100.3F. I'm feeling pretty miserable. Joint pain, aches, chills."

Other Meds: ZOLOFT; ADDERALL; CLARITHROMYCIN; CLONAZEPAM

Current Illness:

ID: 1000612
Sex: F
Age:
State: NY

Vax Date: 01/20/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: neck, back & shoulder pain; neck, back & shoulder pain; neck, back & shoulder pain; headache; exhaustion; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL3247, expiry date not reported), via an unspecified route of administration on 20Jan2021 14:30 at a single dose in the left arm for covid-19 immunization. Medical history included arthritis, high cholesterol, high blood pressure, allergies to food (oats, corn, chocolate), and thyroid (thyroid disorder). The patient was not pregnant at the time of the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam (MOBIC), and other medications the patient received within 2 weeks of vaccination for blood pressure, thyroid, and cholesterol. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 21Jan2021 15:00, patient experienced neck, back and shoulder pain, headache, exhaustion, started 24 hr (hour) after vaccine and resolved in 12 hr (hour). The events were reported as not serious (did not result in death, not life-threatening, did not cause/prolonged hospitalization, not disabling/incapacitating and not a congenital anomaly/birth defect). No treatments received in response to the events reported. Since the vaccination, the patient has not been tested for COVID-19. The outcome of the events neck, back and shoulder pain, headache, and exhaustion was recovered on 22Jan2021 02:00; reported as resolved in 12 hr.

Other Meds: MOBIC

Current Illness:

ID: 1000613
Sex: F
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Chills; fever; headache; pallor then flushing; pallor then flushing; nausea; malaise; muscle aches; extreme fatigue; slept for 16 hours straight; This is a spontaneous report from a contactable nurse reporting for herself. A 55-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular on the right arm on 21Jan2021 08:30 at a SINGLE DOSE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included hypertension from an unknown date and unknown if ongoing. Concomitant medication included hctz (HCTZ). The patient received the first dose last 30Dec2020. On 21Jan2021 09:30 PM, the patient experienced chills, fever, headache, pallor then flushing, nausea, malaise, muscle aches, extreme fatigue and she slept for 16 hours straight. No treatment was received for the events. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: HCTZ

Current Illness:

ID: 1000614
Sex: F
Age:
State: OR

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Muscle aches; Back/flank pain; Back/flank pain; Headache; Low grade fever; Joint pain; Chills; This is a spontaneous report from a contactable nurse (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), intramuscular on the left arm, on 20Jan2021 10:45 at single dose for covid-19 immunisation. The first dose was received on 01Jan2021 09:00, intramuscular on the left arm . Medical history included asthma, depression, and in the midst of getting diagnosed with Sjogerns. Patient was not pregnant at the time of vaccination. Concomitant medication included spironolactone, bupropion, fexofenadine hydrochloride (ALLERFEX) and hair vitamins. The patient experienced muscle aches, back/flank pain, headache, low grade fever, joint pain, and chills on 20Jan2020 17:30. No treatment was received and patient was recovering from the events. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The events were considered non-serious. No follow-up attempts are possible. Information on batch/lot number cannot be obtained. No further information is expected.

Other Meds: SPIRONOLACTONE; BUPROPION; ALLERFEX

Current Illness:

ID: 1000615
Sex: U
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: my heart started racing; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration in Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient took it now and was not sure whether to take the second shot or not, the seconds shot due next Friday. And the day after the patient took it (Jan2021), the patient's heart started racing. "It's did that, I mean it's still doing that off and on is that one of the side effects. Cause I saw but I thought it was immediately after." Outcome of the event was unknown. Information on the lot/ batch number has been requested.

Other Meds:

Current Illness:

ID: 1000616
Sex: F
Age:
State: MA

Vax Date:
Onset Date: 01/07/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data: Test Date: 20210107; Test Name: covid; Test Result: Positive

Allergies:

Symptoms: COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; This is a spontaneous report from a contactable female consumer (patient) from a Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient tested covid positive on 07Jan2021, after she got her first dose of pfizer covid vaccine. The outcome of the event was unknown. Information on the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000617
Sex: M
Age:
State: NC

Vax Date: 01/15/2021
Onset Date: 01/16/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore throat; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL1283 and expiry date: unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient stated that the day after he got the injection, he started to get a sore throat on 16Jan2021. He assumed it was a side effect and the sore throat has not gotten better. It was possibly somewhat worse and was debilitating. He wanted to know if this was a side effect that will go away and what he can do to help it go away. Outcome of the event was not recovered.

Other Meds:

Current Illness:

ID: 1000618
Sex: F
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fever; sore arm; headache; fatigue; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer sales representative. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the following symptoms after vaccination: some fever, sore arm, slight mild headache and fatigue. The outcome of the events was unknown. No follow-up attempts are possible; Information about batch/lot number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1000620
Sex: M
Age:
State: CA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Redness and itching of head and forehead; Redness and itching of head and forehead; hypertension; This is a spontaneous report from a contactable Pharmacist. A 49-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot: EL3302, expiry date: May2021, NDC number: 59267100001) intramuscularly in deltoid right on 20Jan2021 at 0.3 ml single for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporting pharmacist works with a group of five pharmacists. Colleague administered Covid-19 Vaccine to the patient an hour ago. Patient presented with side effects. Pharmacist clarified adverse event as itching of the head and forehead. Forehead looked pretty red and as if there were pimples, but patient was scratching hard. Occurred 15-20 minutes after vaccination (20Jan2021). Pharmacist checked patient for other symptoms of breathing and swelling. Patient stated he was ok in that aspect. Pharmacist gave patient two 25 mg tablets of Benadryl. Pharmacist states patient is healthy and just has hypertension (20Jan2021). Patient is still at the clinic and is going to check back in with caller about how he is doing. Doesn't have exact time of vaccination. Seriousness: At least medically significant. Patient was able to go back to the kitchen and do his job. Pharmacist asked how would he know that is not an allergic reaction and if the second dose should be given. Sticker states NDC is 5926710001, but pharmacist believes NDC is 59267100001. Vaccination Facility Type was Nursing home. Additional Vaccines Administered On Same Date Of Pfizer Suspect was No. Pharmacist makes sure other vaccinations are separated by two weeks. All events required Physician Office Visit. Prior Vaccinations Within 4 Weeks was Unknown. AES Follow Prior Vaccinations was Unknown. Relevant Tests was None. Benadryl allergy tablet, 25 mg NDC: 50580- 226-51 Lot: SFF084 Exp: Feb2022. Pharmacist asked if second dose should be submitted. The outcome of the events was unknown.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events pruritus, erythema and hypertension cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1000621
Sex: F
Age:
State: LA

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Lip and mouth numbness; hoarseness; chest pressure; lightheadedness; This is a spontaneous report from a contactable nurse. A 46-year-old nurse reported that she received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number unknown), at single dose in the Left arm on 15Jan2021 at 11:30 am for COVID-19 immunization.Medical history included allergy to latex. The patient's concomitant medications were not reported. On 15Jan2021 at 12:00 am the patient experienced lip and mouth numbness, hoarseness, chest pressure and lightheadedness. Since the vaccination, the patient has not been tested for COVID. No treatment was received. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1000622
Sex: F
Age:
State: FL

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 02/04/2021
Hospital:

Lab Data:

Allergies:

Symptoms: About 20 minutes after the vaccine was administered I felt a wave of nausea and felt like I was going to vomit; then I felt dizzy; About 20 minutes after the vaccine was administered I felt a wave of nausea and felt like I was going to vomit; diarrhea; This is a spontaneous report from a contactable consumer (patient) A 77-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL324) on 14Jan2021 at 10:00 at single dose via an unspecified route of administration on arm left for COVID-19 immunization. Relevant medical history included GERD, disc disease, meningioma, diverticulitis, panic attack and allergy to Macrodantin, Levaquin and Bactrim. Concomitant medications included metoprolol, atorvastatin, omeprazole and alprazolam. On 14Jan2021 about 20 minutes after the vaccine was administered patient felt a wave of nausea and felt like she was going to vomit, then she felt dizzy. Patient waited another 30 minutes before driving home hoping it would subside. Patient informed she have been nauseated, dizzy and had diarrhea on and off for 9 days. She didn't called her doctor yet or notified anyone at the site hoping it would pass, as she knew that nausea was one of the side effects. The patient was not treated for the events. At the time of the reporting the patient had not yet recovered from the event.

Other Meds: METOPROLOL; ATORVASTATIN; OMEPRAZOLE; ALPRAZOLAM

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm